P66.06 GPNMB Associates With Inferior Prognosis in SCLC Patients Through Promoting Tumor Cell Metastasis

2021 ◽  
Vol 16 (10) ◽  
pp. S1194-S1195
Author(s):  
Q. Liu ◽  
Y. Dong ◽  
S.(. Ren ◽  
C. Zhou
1994 ◽  
Vol 210 (1) ◽  
pp. 1-9 ◽  
Author(s):  
Kenneth V. Honn ◽  
Dean G. Tang ◽  
Irma M. Grossi ◽  
Colette Renaud ◽  
Zofia M. Duniec ◽  
...  

1987 ◽  
Vol 31 (6) ◽  
pp. 342-348 ◽  
Author(s):  
Will J. Kort ◽  
Ineke M. Weijma ◽  
Toos E.M. Stehmann ◽  
Antoine J. Vergroesen ◽  
Dick L. Westbroek

2016 ◽  
Author(s):  
Tamer S. Kaoud ◽  
Xuemei Xie ◽  
Jihyun Park ◽  
Clint D.J. Tavares ◽  
Shreya Mitra ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-16
Author(s):  
Xiaojing Yang ◽  
Hanru Ren ◽  
Xiaomao Guo ◽  
Chaosu Hu ◽  
Jie Fu

The sarcomeric proteins control the movement of cells in diverse species, whereas the deregulation can induce tumours in model organisms and occurs in human carcinomas. Sarcomeric proteins are recognized as oncogene and related to tumor cell metastasis. Recent insights into their expressions and functions have led to new cancer therapeutic opportunities. In this review, we appraise the evidence for the sarcomeric proteins as cancer genes and discuss cancer-relevant biological functions, potential mechanisms by which sarcomeric proteins activity is altered in cancer.


Sign in / Sign up

Export Citation Format

Share Document